News

Find News

Filter articles

Applied Filters

Showing 821 to 830 of 847 results

Takeda sues generics over heartburn drug

US31-05-2013

Japanese pharma company Takeda has sued generic drug-makers Impax and Sandoz for allegedly infringing a patent directed to its anti-heartburn drug Dexilant.

Actavis to buy Warner Chilcott

Ireland, US22-05-2013

Actavis announced on May 20 it will acquire specialty pharmaceutical company Warner Chilcott plc in a deal worth an estimated $5 billion.

IP key to US biosimilars success – report

US15-05-2013

Strong IP knowledge is one of four key factors to succeeding in the burgeoning US biosimilars market, according to an industry report.

AstraZeneca loses Seroquel appeal

UK10-05-2013

The UK Court of Appeal has upheld the High Court’s decision that AstraZeneca’s patent for a sustained release formulation of anti-psychotic drug quetiapine is invalid.

Acura sues Ranbaxy over abuse-resistant generic

US01-05-2013

Acura Pharmaceuticals has sued Ranbaxy Laboratories to keep it from releasing a generic version of its immediate release tablet formulation of painkiller Oxecta.

Actavis eyes $100 million after OxyContin settlement

US29-04-2013

Generic drug-maker Actavis believes it will earn profits of around $100 million in the next two years from licensing patents owned by Purdue Pharma LP.

FTC critical of pay-for-delay in annual report

US24-04-2013

The US Federal Trade Commission has published its annual report for 2012, in which it remains critical of “pay-for-delay” patent settlements.

Shionogi sues Hospira to block Doribax generic

US19-04-2013

Japanese pharma Shionogi has brought a lawsuit against Hospira Inc to keep it from marketing a generic version of Shionogi’s Doribax, alleging it infringes one of the company’s patents.

OFT accuses GSK of market abuse over pay-for-delay deals

UK19-04-2013

The UK Office of Fair Trading has accused GlaxoSmithKline of abusing its market dominance and infringing UK competition law by paying rivals to delay releasing generic versions of its anti-depressant Seroxat.

Novartis sues three over generic Zometa

US17-04-2013

Swiss pharmaceutical firm Novartis has filed a lawsuit against Accord Healthcare, Fresenius Kabi and Hikma Farmaceutica for applying to market generic versions of its cancer drug Zometa.

Showing 821 to 830 of 847 results

LSIPR